C12Y 304/21011
Elastase
Official title: Elastase (3.4.21.11) (C12Y304/21036, C12Y304/21037 take precedence)
C12Y304/21011 (Elastase) appears on 2 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 6
- Assignees
- 6
- Inventors
- 24
- Latest grant
- 12 Apr 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Nicotinamide adenine dinucleotide devices and compositions and methods for making the same27 Aug 2026US 2026/0250695 A1Bio Capital Holdings, LLC
- Protein devices and compositions and methods for making the same30 Jul 2026US 2026/0218214 A1Bio Capital Holdings, LLC
- Systems and methods for epicardial tissue distension solutions12 Mar 2026US 2026/0069665 A1Edwards Lifesciences Corporation
- Oligonucleotide compositions and methods thereof30 Oct 2025US 2025/0333740 A1Wave Life Sciences Ltd.
- Cartilage extract with effect of improving immune response, preparation method therefor, and use thereof30 May 2024US 2024/0173357 A1Beijing Semnl Biotechnology Co., Ltd.
Most cited
By later US patents